These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Bowel wall enhancement in magnetic resonance colonography for assessing activity in Crohn's disease. Röttgen R; Herzog H; Lopez-Häninnen E; Felix R Clin Imaging; 2006; 30(1):27-31. PubMed ID: 16377481 [TBL] [Abstract][Full Text] [Related]
30. Dynamic MRI of the small bowel: usefulness of quantitative contrast-enhancement parameters and time-signal intensity curves for differentiating between active and inactive Crohn's disease. Giusti S; Faggioni L; Neri E; Fruzzetti E; Nardini L; Marchi S; Bartolozzi C Abdom Imaging; 2010 Dec; 35(6):646-53. PubMed ID: 20509025 [TBL] [Abstract][Full Text] [Related]
31. Role of MRI in Crohn's disease. Sinha R; Murphy P; Hawker P; Sanders S; Rajesh A; Verma R Clin Radiol; 2009 Apr; 64(4):341-52. PubMed ID: 19264177 [TBL] [Abstract][Full Text] [Related]
32. Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2-weighted MR imaging in active inflammatory bowel disease. Udayasankar UK; Martin D; Lauenstein T; Rutherford R; Galloway J; Tudorascu D; Sitaraman SV J Magn Reson Imaging; 2008 Nov; 28(5):1133-40. PubMed ID: 18972354 [TBL] [Abstract][Full Text] [Related]
33. Ileal Crohn's disease: MRI with endoscopic correlation. Gallego JC; Echarri AI; Porta A; Ollero V Eur J Radiol; 2011 Nov; 80(2):e8-12. PubMed ID: 20580178 [TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Rimola J; Ordás I; Rodriguez S; García-Bosch O; Aceituno M; Llach J; Ayuso C; Ricart E; Panés J Inflamm Bowel Dis; 2011 Aug; 17(8):1759-68. PubMed ID: 21744431 [TBL] [Abstract][Full Text] [Related]
35. Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CD. Sipponen T; Nuutinen H; Turunen U; Färkkilä M Inflamm Bowel Dis; 2010 Dec; 16(12):2131-6. PubMed ID: 20848462 [TBL] [Abstract][Full Text] [Related]
36. Inflammatory bowel diseases: controversies in the use of diagnostic procedures. Vucelic B Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751 [TBL] [Abstract][Full Text] [Related]
37. Interobserver Agreement in MR Enterography for Diagnostic Assessment in Patients with Crohn's Disease. Schleder S; Pawlik M; Wiggermann P; Ott C; Fichtner-Feigl S; Müller-Wille R; Stroszczynski C; Schreyer AG Rofo; 2013 Sep; 184(10):992-7. PubMed ID: 23893750 [TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging and Crohn's disease endoscopic index of severity: Correlations and concordance. Zhu NY; Zhao XS; Miao F World J Gastroenterol; 2018 Jun; 24(21):2279-2290. PubMed ID: 29881237 [TBL] [Abstract][Full Text] [Related]
39. Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trial. Rutgeerts P; Reinisch W; Colombel JF; Sandborn WJ; D'Haens G; Petersson J; Zhou Q; Iezzi A; Thakkar RB Gastrointest Endosc; 2016 Jan; 83(1):188-97.e1-3. PubMed ID: 26234693 [TBL] [Abstract][Full Text] [Related]
40. Water excitation MPRAGE: an alternative sequence for postcontrast imaging of the abdomen in noncooperative patients at 1.5 Tesla and 3.0 Tesla MRI. Altun E; Semelka RC; Dale BM; Elias J J Magn Reson Imaging; 2008 May; 27(5):1146-54. PubMed ID: 18425826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]